Low formation efficiency of monkey blastoid cavities, typically below 30%, has limited their utility. Here, the authors achieve 80% efficiency from aged/young monkey stem cells and develop a ...

Ruxolitinib is a selective inhibitor of JAK1 and JAK2, widely used for the treatment of high- and intermediate-risk DIPSS plus score prognosis of myelofibrosis, with the aim of improving splenomegaly ...